MENU
ACOG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alpha Cognition (ACOG) Ownership - Who owns Alpha Cognition?
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited or no treatment options... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
143.83M
P/E Ratio
N/A
Total Cash
39.41M
Projected Growth
N/A
Total Debt
2.21M
Revenue
4.59M
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash/Share
2.44
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price
Fundamentals
ACOG
Capitalization
144M
P/E Ratio
N/A
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash
39.4M
Total Cash/Share
2.44
Total Debt
2.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
4.59M
ROE
N/A
Book Value
31.9M
P/B Ratio
4.51
Cash Flow
N/A
Earnings
-1.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
99.2M
Current Ratio
14.69
Current Revenue Per Employee
29082.23
Dividends Per Share - Security
N/A
EBITDA
-19.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
67.78
Revenue To Assets
-84.80
Shares Held By Institutions
38M
Shares Outstanding - Current
16.2M
Total Liabilities
13.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
51.104
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information